|本期目录/Table of Contents|

[1]陈 烁,龚银银,颜景颖,等.CXCR4基因158沉默对膀胱癌T24细胞增殖和凋亡及迁移能力的影响[J].福建医科大学学报,2019,53(03):158-162.
 CHEN Shuo,GONG Yinyin,YAN Jingying,et al.The Effect of Inhibition of CXCR4 Gene by siRNA on the Proliferation Apoptosis and Migration of T24 Bladder Cancer Cells[J].Journal of Fujian Medical University,2019,53(03):158-162.
点击复制

CXCR4基因158沉默对膀胱癌T24细胞增殖和凋亡及迁移能力的影响(PDF)
分享到:

《福建医科大学学报》[ISSN:1672-4194/CN:35-1192/R]

卷:
第53卷
期数:
2019年03期
页码:
158-162
栏目:
论著
出版日期:
2019-06-30

文章信息/Info

Title:
The Effect of Inhibition of CXCR4 Gene by siRNA on the Proliferation Apoptosis and Migration of T24 Bladder Cancer Cells
文章编号:
1672-4194(2019)03-0158-05
作者:
陈 烁1 龚银银2 颜景颖1 汪慧敏1 冉 云1 张 涛1
1.北京中医药大学 深圳医院(龙岗),深圳市龙岗区中医院 外科,龙岗 518100; 2.深圳市第二人民医院 手术室,深圳 518035
Author(s):
CHEN Shuo1 GONG Yinyin2 YAN Jingying1 WANG Huiming1 RAN Yun1 ZHANG Tao1
1.Department of Urology, Traditional Chinese Medicine Hospitals of Longgang District, Shenzhen 518100, China; 2.Department of Anesthesiology, The Second People’s Hospital of Shenzhen, Shenzhen 518035, China
关键词:
膀胱肿瘤 基因 RNA干扰 细胞增殖 细胞运动
Keywords:
uinary bladder neoplasms gene RNA interference cell proliferation cell movement
分类号:
R329.2; R394.2; R737.14
DOI:
-
文献标志码:
A
摘要:
目的 探讨CXCR4基因沉默后对人膀胱癌T24细胞增殖、凋亡、迁移能力的影响。 方法 将T24细胞分为3组,即干扰组、阴性对照组和空白对照组。采用阳离子脂质体转染试剂Lipofectamine 2000将靶向沉默CXCR4基因的小干扰RNA(siRNA)序列转染至膀胱癌T24细胞株中,Western-blot检测转染后T24细胞中CXCR4蛋白的表达水平,MTT比色法检测细胞凋亡,Transwell迁移试验观察T24细胞迁移能力。 结果 转染siRNA后,CXCR4蛋白表达量明显下调(P<0.05),与空白对照组及阴性对照组的T24细胞比较,沉默CXCR4基因后,显著抑制膀胱癌T24细胞的增殖活性(均为P<0.05),促进T24细胞凋亡(均为P<0.05); Transwell实验结果提示,RNAi干扰CXCR4表达后能显著抑制膀胱癌T24细胞的迁移能力(P<0.05)。 结论 RNAi干扰CXCR4表达水平能够抑制T24细胞增殖、促进细胞凋亡及降低细胞的迁移能力,推测CXCR4基因可能是膀胱肿瘤细胞增殖及迁移的重要调控因子之一。
Abstract:
Objective To explore the effect of siRNA targeting the CXCR4 gene on cell proliferation, apoptosis and migration of T24 cells. Methods T24 cells were divided into three groups: interference group, negative control group, and blank control group. Small interfering RNA(siRNA)was transfected together with Lipofectamine 2000 in T24 human bladder cancer cells to block the CXCR4 signal pathway. Western-blot analysis was used to confirm the successful suppression of CXCR4 protein by siRNA. The effect of siRNA on cell death, proliferation and invasiveness was assessed by MTT colorimetric method, cell counting kit-8 assay; the effects of apoptosis was detected by FCM; and Transwell migration assay was performed. Results Expression of CXCR4 protein was successfully suppressed after transfected with siRNA which was verified by Western-blot(P<0.05). Compared with blank control and negative control, the proliferation of T24 bladder cancer cells was successfully restrained and the cell death of T24 bladder cancer cells was significantly promoted by inhibition of CXCR4 gene(all P value<0.05). Transwell test result demonstrated that migration of T24 bladder cancer cells was significantly inhibited after CXCR4 gene was interfered by siRNA(P<0.05). Conclusion This study showed interfering CXCR4 expression level can inhibit cell proliferation, promote cell apoptosis and decreased cell migration ability, which suggested that CXCR4 gene was an important enhancer for the proliferation and migration of bladder cancer cells.

参考文献/References:

[1] Knowles M A, Humt C D. Molocular biology of bladder cancer:new in sights into pathogenesis and clinical diversity[J]. Nat Rev Cancer, 2015,15(1):25-41.[2] Babjuk M, Bohle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016[J]. Eur Uro, 2017,71(3):447-461.[3] Li Y, Chen M, Yuan J, et al. CXCR4 expression in bladder transitional cell carcinoma and its relationship with clinicopathological features[J]. Urol Int, 2014,92(2):157-163.[4] Huang A F, Chen M W, Huang S M, et al. CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1alpha/CXCR4 axis[J]. Mol Cancer, 2013,12(1):115-127.[5] Caronni N,Savino B, Recordati C, et al. Cancer and chemokines[J]. Methods Molbiol, 2016,1393:87-96.[6] Sakai N, Yoshidome H, Shida T, et al. CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer[J]. Clin Exp Metas, 2012,29(2):101-110.[7] Righi E, Kashiwagi S, Yuan J, et al. CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer[J]. Can Res, 2011,71(16):5522-5534.[8] Kinoshita H, Yashiro M, Fukuoka T,et al. Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor micro-environments[J]. Carcinogenesis, 2015,36(12):1511-1520.[9] Tsai H H, Niu J, Munji R, et al. Oligodendrocyte precursors migrate along vasculature in the developing nervous system[J]. Science, 2016,351(6271):379-388.[10] Danylesko I, Sareli R, Varda-Bloom N, et al. Plerixafor(Mozobil):A stem cell-mobilizing agent for transplantation in lymphoma patients predicted to be poor mobilizers-a pilot study[J]. Acta Haematol, 2016,135(1):29-36.[11] Sand L G, Scotlandi K, Berghuis D, et al. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients[J]. Eur J Cancer, 2015,51(17):2624-2633.[12] Guembarovski A L, Guembarovski R L, Hirata B K B, et al. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer[J]. Mol Biol Rep, 2018,45(5):741-750.[13] 李康华, 龙海涛, 曾庆华, 等. CXCR4在骨肉瘤组织中的表达[J]. 生命科学研究, 2008,12(1):50-52.[14] 姚继方, 王明正. CXCR4、HPA在非小细胞肺癌组织中的表达及意义[J]. 河北医药, 2010,32(16):2162-2164.[15] Akashi T, Koizumi K, Tsuneyama K, et al.Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer[J].Cancer Sci, 2008,99(3):539-542.[16] 梁鼎天, 李泉旺, 张 涛. 骨肉瘤中SDF-1/CXCR4通路功能分析及外源性给予SDF-1对骨肉瘤细胞的调节作用[J]. 海南医学院学报, 2016,22(8):736-739.[17] 叶明宝, 田俊强, 常 宏, 等. SDF-1/CXCR4在膀胱癌组织中的表达及其与负性共刺激分子PD-L1、细胞凋亡和侵袭性的相关性研究[J]. 海南医学院学报, 2017,23(6):736-742.[18] 郑湘予, 庞 霞, 李晟磊, 等. CXCR4基因沉默后对T24膀胱癌细胞株裸鼠移植瘤的影响[J]. 中国现代医学杂志, 2012,22(33):13-18.[19] 杜岳峰, 龙清志, 樊桂玲, 等. hTERT启动子调控的CXCR4-shRNA逆转录病毒抑制膀胱癌细胞侵袭、增殖的体外研究[J]. 现代泌尿外科杂志, 2009,14(4):273-277.

相似文献/References:

[1]郑培烝,邹 红,傅芬蕊,等.重症监护室耐碳青酶烯类鲍曼不动杆菌的基因分型[J].福建医科大学学报,2014,48(01):57.
 ZHENG Peizheng,ZOU Hong,FU Fenrui,et al.Genotyping of Carbapenem-resistant AcinetobacterBaumannii Strains Isolated from Intensive Care Units[J].Journal of Fujian Medical University,2014,48(03):57.
[2]钟泉,闫福华,李艳芬,等.hPDGF-B基因转染对Beagle犬牙龈成纤维细胞生物学活性的影响[J].福建医科大学学报,2013,47(06):329.
 ZHONG Quan,YAN Fuhua,LI Yanfen,et al.Biological Effects of Human PlateletDerived Growth FactorB Gene Transfection on Gingival Fibroblasts of Beagle Dog[J].Journal of Fujian Medical University,2013,47(03):329.
[3]黄东红,郑友限,潘少敏,等.泉州市6例布鲁菌病的微生物生化鉴定及分子生物学确认[J].福建医科大学学报,2014,48(02):125.
 HUANG Donghong,ZHENG Youxian,PAN Shaomin,et al.Comparative Identification between Biochemical and Molecular Biological Method of Six Strains of Brucellosis in Quanzhou City[J].Journal of Fujian Medical University,2014,48(03):125.
[4]唐松喜,曹林升,周辉良,等.错配修复基因hMSH2表达与膀胱移行细胞癌预后关系的研究[J].福建医科大学学报,2014,48(03):164.
 TANG Songxi,CAO Linsheng,ZHOU Huiliang,et al.Relationship between the Expression of hMSH2 and Prognosis in Patients with Bladder Transitional Cell Carcinoma[J].Journal of Fujian Medical University,2014,48(03):164.
[5]蔡江萍,李国前,慕容慎行,等.LRRK2基因多态性与散发性阿尔茨海默病相关性的研究[J].福建医科大学学报,2014,48(03):169.
 CAI Jiangping,LI Guoqian,MURONG Shenxing,et al.Association between Polymorphisms of the LRRK2 Gene and Sporadic Alzheimer’s Disease[J].Journal of Fujian Medical University,2014,48(03):169.
[6]何保昌,陈 法,刘芳萍,等.福建地区口腔癌患者p53基因72密码子多态性与口腔癌易感性的研究[J].福建医科大学学报,2014,48(06):372.
 HE Baochang,CHEN Fa,LIU Fangping,et al.Study on p53 Gene Condon 72 Polymorphisms and Susceptibilityof Oral Cancer of Fujian Oral Cancer Patients[J].Journal of Fujian Medical University,2014,48(03):372.
[7]陈金烟,韩俊永,薛士杰,等.MDA-7/IL-24对食管癌细胞的增殖和存活影响[J].福建医科大学学报,2014,48(05):290.
 CHEN Jinyan,HAN Junyong,XUE Shijie,et al.Adenovirus Vector Expressing MDA-7/IL-24 Induces Growth Arrestsand Apoptosis in Human Esophageal Cancer Cell Lines[J].Journal of Fujian Medical University,2014,48(03):290.
[8]陈 新,叶兴安,李仔峰,等.肝细胞核因子在卵巢透明细胞癌中的表达及其意义[J].福建医科大学学报,2014,48(05):299.
 CHEN Xin,YE Xingan,LI Zaifeng,et al.The Expression and Significance of HNF-1β in Ovarian Clear Cell Carcinoma[J].Journal of Fujian Medical University,2014,48(03):299.
[9]林善明,李增棋,王航,等.华法林个体化剂量与CYP2C9/VKORC1基因组之间的关系[J].福建医科大学学报,2015,49(02):120.
 LIN Shanming,LI Zengqi,WAN Hang,et al.Investigation of the Relationship between the Individual Warfarin Dosing and the Pharmacogenomics[J].Journal of Fujian Medical University,2015,49(03):120.
[10]生秀梅,王正新.BTG2基因重组慢病毒载体的构建及其在肺癌A549细胞中的表达与功能[J].福建医科大学学报,2016,50(02):74.
 SHENG Xiumei,WANG Zhengxin.Construction of Recombinant Lentiviral Vector pCDH-BTG2 and Its Expression and Function in A549 Cells[J].Journal of Fujian Medical University,2016,50(03):74.
[11]袁 远,黄恩应,陈小刚.LASS2在膀胱癌组织中的表达及对细胞增殖和侵袭能力的影响[J].福建医科大学学报,2018,52(05):311.
 YUAN Yuan,HUANG Enying,CHEN Xiaogang.Expression of LASS2 in Human Bladder Cancer Tissue andIts Effect on Cell Proliferation and Invasion[J].Journal of Fujian Medical University,2018,52(03):311.

备注/Memo

备注/Memo:
收稿日期: 2018-07-16;基金项目: 广东省深圳市科技创新委员会课题(JCYJ20160427160214557);作者简介: 陈 烁,男,主治医师;通讯作者: 张 涛. Email:Zhangtaomed@163.com
更新日期/Last Update: 2019-06-30